Zentiva announces the acquisition of Creo Pharmaceuticals Ltd. in the UK
PRAGUE – April 1st, 2019: Zentiva Group a.s. is announcing the acquisition of Creo Pharmaceuticals Ltd. in the UK, a subsidiary of Amneal Pharmaceuticals, Inc. (NYSE: AMRX).
Nick Haggar, CEO of Zentiva stated: “Zentiva is delighted to confirm the acquisition of Creo Pharma which will strengthen Zentiva’s position in the UK. This move reflects our confidence in the UK and our deep commitment to the development, manufacture and supply of high-quality affordable medicines. We welcome the Creo Pharma team who have a strong reputation for providing high-quality services to their customers.”
“We are happy to join Zentiva as we are convinced that the combination of our two businesses will bring value to our customers and to patients in the UK. We believe the combination of Creo and Zentiva will allow us to accelerate our growth and achieve our full potential,” said Luke Hart, Managing Director of Creo Pharmaceuticals Ltd.
At Zentiva we aspire that healthcare should be a right and not a privilege. More than ever, people need better access to healthcare. Today, the everyday solutions that we all depend on truly count as a vital foundation of healthy living. Zentiva works for the people living in Europe. Standing side-by-side with healthcare professionals, pharmacists and Health System decision-makers, we have the same sense of social obligation to help lower costs and improve access to healthcare. With more than 2,500 people across Europe and 2 production sites in Prague and Bucharest we strive to be the champions of Generics and OTC medicines to better support people’s daily healthcare needs.
About Creo Pharmaceuticals Ltd.
Creo Pharma was established in 2007 to provide supply partners with direct marketing access in the UK generics market. We are a reputable, reliable and expanding UK pharmaceutical provider with a key focus on supplying the wholesale, pharmacy and hospital sectors with everything from generic medicines to commercial brands. Creo’s success is built upon strong customer relationships, exceptional support and a diverse product portfolio. We understand that trust and reliability are vital requirements for today’s fast-paced generics environment and fulfil these demands with a friendly, professional customer service team. Our core aims are centred around our customers priorities, ensuring medical professionals and patients alike have access to a host of unique products.